NASDAQ:PALI

Palisade Bio Stock Insider Trading

etoro logo Buy PALI
*Your capital is at risk
$1.93
+0.0700 (+3.76%)
At Close: Jun 03, 2026

Palisade Bio Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.67. In total, the insiders bought 43.73M and sold 12.76K PALI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
99.67
Buy 43.73M shares
Sell 12.76K shares
84% Buy Activity
Weak Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Feb 12, 2026
Sell
Common Stock
S-Sale
Jones Mitchell Lawrence
Chief Medical Officer
Officer 1 989
Value: $3K
Feb 12, 2026
Sell
Common Stock
S-Sale
Finley John David
CEO, CFO
CEO / President 3 896
Value: $7K
Feb 11, 2026
Buy
Restricted Stock Units
M-Exempt
Jones Mitchell Lawrence
Chief Medical Officer
Officer 8 000
Value: $13.9K
Feb 11, 2026
Buy
Common Stock
M-Exempt
Jones Mitchell Lawrence
Chief Medical Officer
Officer 8 000
Value: $13.9K
Feb 11, 2026
Buy
Common Stock
M-Exempt
Finley John David
CEO, CFO
CEO / President 13 333
Value: $23.2K
Feb 11, 2026
Buy
Restricted Stock Units
M-Exempt
Finley John David
CEO, CFO
CEO / President 13 333
Value: $23.2K
Feb 09, 2026
Buy
Restricted Stock Units
A-Award
Jones Mitchell Lawrence
Chief Medical Officer
Officer 787 000
Value: $1.35M
Feb 09, 2026
Buy
Restricted Stock Units
A-Award
Finley John David
CEO, CFO
CEO / President 2 011 000
Value: $3.46M
Jan 16, 2026
Buy
Common Stock
P-Purchase
Williams Donald Allen
Director
Director 5 000
Value: $8K
Jan 09, 2026
Buy
Common Stock
P-Purchase
Williams Donald Allen
Director
Director 5 000
Value: $9K
Oct 06, 2025
Buy
Restricted Stock Units
A-Award
Williams Donald Allen
Director
Director 182 000
Value: $346.7K
Oct 06, 2025
Buy
Restricted Stock Units
A-Award
Wei Binxian
Director
Director 60 600
Value: $115.4K
Oct 06, 2025
Buy
Restricted Stock Units
A-Award
Chuang Emil
Director
Director 60 600
Value: $115.4K
Oct 06, 2025
Buy
Restricted Stock Units
A-Award
Williams Donald Allen
Director
Director 1 538 700
Value: $2.93M
Oct 06, 2025
Buy
Restricted Stock Units
A-Award
Wei Binxian
Director
Director 510 700
Value: $972.9K
Oct 06, 2025
Buy
Restricted Stock Units
A-Award
Jones Mitchell Lawrence
Chief Medical Officer
Officer 7 665 800
Value: $14.6M
Oct 06, 2025
Buy
Restricted Stock Units
A-Award
Finley John David
CEO, CFO
CEO / President 9 179 400
Value: $17.5M
Oct 06, 2025
Buy
Restricted Stock Units
A-Award
Chuang Emil
Director
Director 510 700
Value: $972.9K
Oct 06, 2025
Buy
Restricted Stock Units
A-Award
Chuang Emil
Director
Director 510 700
Value: $972.9K
Oct 06, 2025
Buy
Restricted Stock Units
A-Award
Finley John David
CEO, CFO
CEO / President 9 179 400
Value: $17.5M
Oct 06, 2025
Buy
Restricted Stock Units
A-Award
Jones Mitchell Lawrence
Chief Medical Officer
Officer 7 665 800
Value: $14.6M
Oct 06, 2025
Buy
Restricted Stock Units
A-Award
Wei Binxian
Director
Director 510 700
Value: $972.9K
Oct 06, 2025
Buy
Restricted Stock Units
A-Award
Williams Donald Allen
Director
Director 1 538 700
Value: $2.93M
Sep 04, 2025
Buy
Phantom Units
A-Award
Williams Donald Allen
Director
Director 64 400
Value: $40.7K
Sep 04, 2025
Buy
Phantom Units
A-Award
Finley John David
CEO, CFO
CEO / President 323 400
Value: $204.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PALISADE BIO, INC.
Palisade Bio
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during int...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE